These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32432955)

  • 21. May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa?
    Caposiena Caro RD; Pensa C; Lambiase S; Candi E; Bianchi L
    Ital J Dermatol Venerol; 2021 Oct; 156(5):616-617. PubMed ID: 34282868
    [No Abstract]   [Full Text] [Related]  

  • 22. The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy.
    Ciechanowicz P; Dopytalska K; Mikucka-Wituszyńska A; Dźwigała M; Wiszniewski K; Herniczek W; Szymańska E; Walecka I
    J Dermatolog Treat; 2022 May; 33(3):1581-1584. PubMed ID: 33317364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic.
    Penso L; Dray-Spira R; Weill A; Zureik M; Sbidian E
    Br J Dermatol; 2021 Sep; 185(3):671-673. PubMed ID: 33894022
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.
    Torres T; Puig L
    Am J Clin Dermatol; 2020 Jun; 21(3):307-311. PubMed ID: 32277351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19: The Italian experience.
    Musumeci ML; Nasca MR; Micali G
    Clin Dermatol; 2021; 39(3):418-423. PubMed ID: 34517999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should patients stop their biologic treatment during the COVID-19 pandemic.
    Bashyam AM; Feldman SR
    J Dermatolog Treat; 2020 Jun; 31(4):317-318. PubMed ID: 32191143
    [No Abstract]   [Full Text] [Related]  

  • 27. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
    Berman HS; Villa NM; Shi VY; Hsiao JL
    J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience in patients with hidradenitis suppurativa and COVID-19 symptoms.
    Galán JL; Silvente C; González M; García C; Díez K; Martín MÁ; Velázquez D; de la Cueva P
    J Am Acad Dermatol; 2020 Oct; 83(4):e309-e311. PubMed ID: 32603717
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
    Bragazzi NL; Riccò M; Pacifico A; Malagoli P; Kridin K; Pigatto P; Damiani G
    Dermatol Ther; 2020 Jul; 33(4):e13508. PubMed ID: 32415727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa.
    Seltzer JA; Okeke CAV; Perry JD; Shipman WD; Okoye GA; Byrd AS
    J Am Acad Dermatol; 2020 Aug; 83(2):e153-e154. PubMed ID: 32389715
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of the COVID-19 pandemic on biologic treatment in psoriasis patients: A single-center retrospective study in Japan.
    Uchida H; Kamata M; Egawa S; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2022 Jun; 49(6):624-628. PubMed ID: 35319126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?
    Dewigne M; Orte Cano C; Daoud M; Del Marmol V; Benhadou F
    Exp Dermatol; 2022 Mar; 31(3):435-436. PubMed ID: 34679208
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 and psoriasis: biologic treatment and challenges.
    Ebrahimi A; Sayad B; Rahimi Z
    J Dermatolog Treat; 2022 Mar; 33(2):699-703. PubMed ID: 32598204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".
    Potestio L; Camela E; Fabbrocini G; Megna M
    J Cosmet Dermatol; 2021 Dec; 20(12):4073-4075. PubMed ID: 34708906
    [No Abstract]   [Full Text] [Related]  

  • 35. Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II.
    Camela E; Fabbrocini G; Cinelli E; Lauro W; Megna M
    Dermatology; 2021; 237(1):13-14. PubMed ID: 33296899
    [No Abstract]   [Full Text] [Related]  

  • 36. Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.
    Williams JC; Alhusayen R; Guilbault S; Hills NK; Ingram JR; Kudlinski MV; Lowes MA; Marzano AV; Paul M; Villumsen B; Yannuzzi CA; Naik HB
    Dermatology; 2023; 239(2):283-286. PubMed ID: 36566748
    [No Abstract]   [Full Text] [Related]  

  • 37. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
    Tampouratzi E; Kanni T; Katsantonis J; Douvali T
    F1000Res; 2019; 8():2002. PubMed ID: 33456757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and incidence of hidradenitis suppurativa: an exercise on indirect estimation from psoriasis data.
    Fania L; Ricci F; Sampogna F; Mazzanti C; Didona B; Pintori G; Abeni D
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e410-e411. PubMed ID: 28300328
    [No Abstract]   [Full Text] [Related]  

  • 39. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.
    Conforti C; Giuffrida R; Dianzani C; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Jul; 33(4):e13490. PubMed ID: 32358864
    [No Abstract]   [Full Text] [Related]  

  • 40. Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
    Rob F; Hugo J; Tivadar S; Boháč P; Gkalpakiotis S; Vargová N; Arenbergerová M; Hercogová J
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e682-e684. PubMed ID: 32594549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.